SCHEMBL8915955

SCHEMBL8915955

CCCCCCCCCCCCCCCCCCCCCCOS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
RECQL P46063 2/20 0.49
MAPK1 P28482 2/20 0.49
GLA P06280 1/20 0.49
HPGD P15428 1/20 0.49
EPHX2 P34913 1/20 0.49
BLM P54132 1/20 0.49
CA2 P00918 11/20 0.46
CA1 P00915 10/20 0.46
CA9 Q16790 9/20 0.46
CA12 O43570 4/20 0.46
CA7 P43166 4/20 0.46
CA14 Q9ULX7 3/20 0.46
CA3 P07451 2/20 0.46
CA4 P22748 2/20 0.46
CA6 P23280 2/20 0.46
CA5A P35218 2/20 0.46
CA5B Q9Y2D0 2/20 0.46
CNR2 P34972 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123596 1.00 TSHR (0.49) TSHRRECQLMAPK1GLAHPGD
SCHEMBL8921158 1.00 TSHR (0.49) TSHRRECQLMAPK1GLAHPGD
SCHEMBL8920377 1.00 TSHR (0.49) TSHRRECQLMAPK1GLAHPGD
SCHEMBL8926435 1.00 TSHR (0.49) TSHRRECQLMAPK1GLAHPGD
SCHEMBL10870886 1.00 TSHR (0.49) TSHRRECQLMAPK1GLAHPGD
SCHEMBL4192257 0.98 RECQL (0.46) TSHRRECQLMAPK1GLAHPGD
SCHEMBL27649743 0.93 CA2 (0.46) TSHRRECQLMAPK1GLAHPGD
SCHEMBL27995614 0.91 RECQL (0.57) TSHRRECQLMAPK1GLAHPGD
SCHEMBL27520719 0.91 RECQL (0.57) TSHRRECQLMAPK1GLAHPGD
SCHEMBL27550478 0.90 RECQL (0.55) TSHRRECQLMAPK1GLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170239377-A1 MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS UNIV MASSACHUSETTS (US) 2017-08-24 US disclosed
US-9492571-B2 Molecular probes for multimodality imaging and tracking of stem cells UNIVERSITY OF MASSACHUSETTS (US) 2016-11-15 US disclosed
US-20150125388-A1 MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS Vniversity of Massachusetts Medical School (US) 2015-05-07 US disclosed
WO-2013181119-A1 MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL (US) 2013-12-05 WO disclosed
US-5667764-A USEFUL IN TREATMENT OF POST-ANGIOPLASTY RESTENOSIS, RHEUMATOID ARTHRITIS, TUMOR CELL PROLIFERATION AND PSORIASIS ZYNAXIS, INC. (US) 1997-09-16 US disclosed
US-5665328-A USING SELECTED DYE AS BINDING AGENT WITHOUT PRODUCING DETRIMENTAL EFFECT ON MORPHOLOGY OR PHYSIOLOGICAL FUNCTION OF CELLS PHANOS TECHNOLOGIES, INC. (US) 1997-09-09 US disclosed
EP-0430968-B1 COMPOUNDS, COMPOSITIONS AND METHOD FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES PHANOS TECH INC (US) 1996-11-20 EP disclosed
EP-0643706-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES Zynaxis Inc. (US) 1995-03-22 EP disclosed
EP-0643706-A4 COMPOUNDS, COMPOSITIONS AND METHODS FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES. ZYNAXIS INC (US) 1994-12-27 EP disclosed
EP-0430968-A4 COMPOUNDS, COMPOSITIONS AND METHOD FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES 1993-10-20 EP disclosed
WO-1993011120-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES ZYNAXIS TECHNOLOGIES, INCORPORATED (US) 1993-06-10 WO disclosed
EP-0430968-A1 COMPOUNDS, COMPOSITIONS AND METHOD FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES. ZYNAXIS TECHNOLOGIES INC (US) 1991-06-12 EP disclosed
WO-1989010758-A1 COMPOUNDS, COMPOSITIONS AND METHOD FOR BINDING BIO-AFFECTING SUBSTANCES TO SURFACE MEMBRANES OF BIO-PARTICLES ZYNAXIS TECHNOLOGIES, INC. (US) 1989-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150125388-A1 MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS CD44, FABP3, FABP7 TSHR 1906/4885RECQL 3651/4885MAPK1 4505/4885
US-20170239377-A1 MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS CD44, FABP3, FABP7 TSHR 1906/4885RECQL 3651/4885MAPK1 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.